Bain Capital Life Sciences Investors as of March 31, 2023
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 34 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 13.8 | $110M | 8.3M | 13.26 | |
| Nuvalent Inc-a (NUVL) | 11.7 | $93M | 3.6M | 26.09 | |
| Springworks Therapeutics (SWTX) | 9.9 | $79M | 3.1M | 25.74 | |
| Disc Medicine (IRON) | 5.3 | $42M | 2.0M | 21.19 | |
| Natera (NTRA) | 4.9 | $39M | 700k | 55.52 | |
| Dynavax Technologies Corp Com New (DVAX) | 4.8 | $38M | 3.9M | 9.81 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.6 | $37M | 2.3M | 16.06 | |
| Mersana Therapeutics (MRSN) | 4.5 | $36M | 8.7M | 4.11 | |
| Arcutis Biotherapeutics (ARQT) | 4.1 | $33M | 3.0M | 11.00 | |
| Aclaris Therapeutics (ACRS) | 3.4 | $28M | 3.4M | 8.09 | |
| Pharvaris N V (PHVS) | 3.2 | $26M | 3.2M | 8.06 | |
| Savara (SVRA) | 2.8 | $23M | 12M | 1.95 | |
| Cymabay Therapeutics | 2.7 | $22M | 2.5M | 8.72 | |
| Cti Biopharma | 2.5 | $20M | 4.7M | 4.20 | |
| Eqrx | 2.4 | $19M | 10M | 1.94 | |
| Annexon (ANNX) | 2.4 | $19M | 4.9M | 3.85 | |
| Nurix Therapeutics (NRIX) | 2.0 | $16M | 1.8M | 8.88 | |
| Solid Biosciences Com New (SLDB) | 1.9 | $15M | 3.1M | 4.74 | |
| 2seventy Bio Common Stock (TSVT) | 1.8 | $14M | 1.4M | 10.20 | |
| Rapid Micro Biosystems Class A Com (RPID) | 1.4 | $11M | 8.4M | 1.31 | |
| Cara Therapeutics (CARA) | 1.4 | $11M | 2.2M | 4.91 | |
| X4 Pharmaceuticals (XFOR) | 1.3 | $11M | 12M | 0.87 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.2 | $9.9M | 1.4M | 6.90 | |
| Xilio Therapeutics (XLO) | 1.1 | $8.9M | 2.8M | 3.17 | |
| Atea Pharmaceuticals (AVIR) | 1.0 | $8.3M | 2.5M | 3.35 | |
| Tango Therapeutics (TNGX) | 0.9 | $7.6M | 1.9M | 3.95 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.7 | $5.7M | 2.1M | 2.67 | |
| Nautilus Biotechnology (NAUT) | 0.7 | $5.5M | 2.0M | 2.77 | |
| C4 Therapeutics Com Stk (CCCC) | 0.6 | $5.2M | 1.6M | 3.14 | |
| Third Harmonic Bio (THRD) | 0.3 | $2.6M | 641k | 4.12 | |
| Adagio Therapeutics (IVVD) | 0.3 | $2.3M | 1.9M | 1.20 | |
| Aeglea Biotherapeutics | 0.2 | $1.6M | 5.3M | 0.29 | |
| Aptinyx | 0.1 | $1.1M | 8.9M | 0.12 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 (NAMSW) | 0.0 | $184k | 100k | 1.84 |
